Olayinka O. Ajani

A Correction on Emerging insights into chemistry and therapeutic potentials of functionalized hexahydroquinolines by Oduselu GO, Olatuyi RO, Fatoki OO, Bodun DS, Sunday PE, Oyibo W and Ajani OO (2026). Front. Chem. 14:1769586. doi: 10.3389/fchem.2026.1769586 There was a mistake in Table 1, Scheme 2 as published. One of the key reagents mentioned in table (S/N 2) as part of the Antaki synthesis of hexahydroquinoline derivatives was wrongly written as “Cyclohexane-1,2-dione”.

Abstract Quinolines are well-established scaffolds in drug discovery and form the core of many FDA-approved medicines. Among their reduced analogues, hexahydroquinolines (HHQs) have gained increasing attention due to their structural adaptability and broad pharmacological relevance. Research has largely focused on the 1,4,5,6,7,8-hexahydroquinoline framework, although interest in other variants, including 2-oxo derivatives, is steadily growing.